Summary

Software as a Medical Device (SaMD) Trends and Forecast
The future of the global software as a medical device market (SaMD) looks promising with opportunities in the screening & diagnostic, monitoring & alerting, and disease management markets. The global software as a medical device market (SaMD) is expected to reach an estimated $8.4 billion by 2030 with a CAGR of 10.3% from 2024 to 2030. The major drivers for this market are increasing demand for remote patient monitoring by healthcare providers, stringent regulatory requirements, and growing adoption of digital health technologies.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Software as a Medical Device (SaMD) by Segment
The study includes a forecast for the global software as a medical device (SaMD) by device type, deployment type, application, and region.

Software as a Medical Device Market (SaMD) by Device Type [Shipment Analysis by Value from 2018 to 2030]:
• PCs/Laptops
• Smartphone/Tablets
• Wearable Devices

Software as a Medical Device Market (SaMD) by Deployment Type [Shipment Analysis by Value from 2018 to 2030]:
• Cloud
• On-Premise

Software as a Medical Device Market (SaMD) by Application [Shipment Analysis by Value from 2018 to 2030]:
• Screening & Diagnostics
• Monitoring & Alerting
• Disease Management
• Others

Software as a Medical Device Market (SaMD) by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Software as a Medical Device (SaMD) Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies software as a medical device (SaMD) companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the software as a medical device (SaMD) companies profiled in this report include-
• Velentium
• Tietronix Software
• S3 Connected Health
• Zühlke Group
• Science Group
• Inzentiz
• Cambridge Consultants
• BrightInsight
• CompliancePath
• Jabil


Software as a Medical Device (SaMD) Market Insights
Lucintel forecasts that PC/laptop will remain the largest segment over the forecast period due to its increasing adoption for conducting various monitoring and advanced healthcare diagnostics through new features.
Within this market, screening & diagnostic will remain the largest segment.
APAC will remain the largest region over the forecast period due to improvement of the healthcare infrastructure and the rising number of healthcare entrepreneurs in this region.

Features of the Global Software as a Medical Device Market (SaMD)

Market Size Estimates: Software as a medical device market (SaMD) size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Software as a medical device market (SaMD) size by device type, deployment type, application, and region in terms of value ($B).
Regional Analysis: Software as a medical device market (SaMD) breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different device types, deployment types, applications, and regions for the software as a medical device market (SaMD).
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the software as a medical device market (SaMD).
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the software as a medical device market (SaMD) size?
Answer: The global software as a medical device market (SaMD) is expected to reach an estimated $8.4 billion by 2030.

Q2. What is the growth forecast for software as a medical device market (SaMD)?
Answer: The global software as a medical device market (SaMD) is expected to grow with a CAGR of 10.3% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the software as a medical device market (SaMD)?
Answer: The major drivers for this market are increasing demand for remote patient monitoring by healthcare providers, stringent regulatory requirements, and growing adoption of digital health technologies.

Q4. What are the major segments for software as a medical device market (SaMD)?
Answer: The future of the software as a medical device market (SaMD) looks promising with opportunities in the screening & diagnostic, monitoring & alerting, and disease management markets.

Q5. Who are the key software as a medical device market (SaMD) companies?
Answer: Some of the key software as a medical device (SaMD) companies are as follows:
• Velentium
• Tietronix Software
• S3 Connected Health
• Zühlke Group
• Science
• Inzentiz
• Cambridge Consultants
• BrightInsight
• CompliancePath
• Jabil

Q6. Which software as a medical device market (SaMD) segment will be the largest in future?
Answer: Lucintel forecasts that PC/laptop will remain the largest segment over the forecast period due to its increasing adoption for conducting various monitoring and advanced healthcare diagnostics through new features.

Q7. In software as a medical device market (SaMD), which region is expected to be the largest in next 5 years?
Answer: APAC will remain the largest region over the forecast period due to improvement of the healthcare infrastructure and the rising number of healthcare entrepreneurs in this region.

Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the software as a medical device market (SaMD) by device type (PCs/laptops, smartphone/tablets, and wearable devices), deployment type (cloud and on-premise), application (screening & diagnostics, monitoring & alerting, disease management, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

ページTOPに戻る

Table of Contents